Search - tctmd.com

Displaying 761 - 780 of 1179

Sort: Relevancy | Date

News Daily News

Lower-Profile Graft for TEVAR Demonstrates Safety, Device Success Out to 1 Year

L.A. McKeown

August 10, 2015

News Features

Opportunities Exist for Hospitals, Interventionalists to Stave Off Unnecessary Readmissions

July 28, 2015

News Industry News

ISIS Pharmaceuticals Reports Data from ISIS-TTR Rx in patients with Transthyretin Amyloid-Related Cardiomyopathy

July 27, 2015

News Industry News

Micell Technologies Announces First Patient Enrolled in Registration Trial of MiStent SES in China

July 22, 2015

News Daily News

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Yael L. Maxwell

July 15, 2015

News Daily News

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

July 07, 2015

News Daily News

RIBS IV: EES Surpass DCB for Treatment of In-Stent Restenosis

L.A. McKeown

July 01, 2015

News Industry News

First patient enrolled in Pivotal's POMEGA Phase IIa clinical trial with PVT-100

June 04, 2015

News Industry News

Expert panel publishes guidance for central aortic pressure waveform analysis in patient care

May 27, 2015

News Conference News EuroPCR 2015

Trials Explore the Potential of Biodegradable-Polymer Stents

Caitlin E. Cox

May 21, 2015

News Conference News EuroPCR 2015

Positive Signs for OCT Guidance in PCI

Caitlin E. Cox

May 20, 2015

News Industry News

Medtronic Drug-Coated Balloon for Treatment of Peripheral Arterial Disease Shows Strong Results in Long Lesions

May 20, 2015

News Daily News

More Data Support Mechanical Thrombectomy in Acute Stroke Treatment

L.A. McKeown

April 29, 2015

News Daily News

New SCAI Survey Shows Interventionalists Still Plagued by Occupational Health Hazards

Yael L. Maxwell

April 09, 2015

News Conference News ACC 2015

MATRIX Provides Support for Radial Access, Mixed Results for Bivalirudin

Todd Neale

March 17, 2015

News Conference News ACC 2015

Study EMBRACEs Novel Drug, But Fails to Reduce Infarct Size in Anterior STEMI

Yael L. Maxwell

March 15, 2015

News Conference News ACC 2015

Anticoagulation With Off-Switch Fails to Improve PCI Outcomes, Sparks Allergic Reactions

Todd Neale

March 15, 2015

News Industry News

New Data from IMPROVE-IT Study of VYTORIN® (ezetimibe-simvastatin) and TRA 2ºP TIMI 50 Study of ZONTIVITY® (vorapaxar) to be Presented at American College of Cardiology Scientific Sessions

February 24, 2015

News Daily News

Vorapaxar es Eficaz como Prevención Secundaria en Pacientes Diabéticos con Antecedentes de IM

L.A. McKeown

February 22, 2015

Advertisement

Lower-Profile Graft for TEVAR Demonstrates Safety, Device Success Out to 1 Year

Opportunities Exist for Hospitals, Interventionalists to Stave Off Unnecessary Readmissions

ISIS Pharmaceuticals Reports Data from ISIS-TTR Rx in patients with Transthyretin Amyloid-Related Cardiomyopathy

Micell Technologies Announces First Patient Enrolled in Registration Trial of MiStent SES in China

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

RIBS IV: EES Surpass DCB for Treatment of In-Stent Restenosis

First patient enrolled in Pivotal's POMEGA Phase IIa clinical trial with PVT-100

Expert panel publishes guidance for central aortic pressure waveform analysis in patient care

Trials Explore the Potential of Biodegradable-Polymer Stents

Positive Signs for OCT Guidance in PCI

Medtronic Drug-Coated Balloon for Treatment of Peripheral Arterial Disease Shows Strong Results in Long Lesions

More Data Support Mechanical Thrombectomy in Acute Stroke Treatment

New SCAI Survey Shows Interventionalists Still Plagued by Occupational Health Hazards

MATRIX Provides Support for Radial Access, Mixed Results for Bivalirudin

Study EMBRACEs Novel Drug, But Fails to Reduce Infarct Size in Anterior STEMI

Anticoagulation With Off-Switch Fails to Improve PCI Outcomes, Sparks Allergic Reactions

New Data from IMPROVE-IT Study of VYTORIN® (ezetimibe-simvastatin) and TRA 2ºP TIMI 50 Study of ZONTIVITY® (vorapaxar) to be Presented at American College of Cardiology Scientific Sessions

Vorapaxar es Eficaz como Prevención Secundaria en Pacientes Diabéticos con Antecedentes de IM

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content